糖尿病患者-话题@MedSci

#糖尿病患者#

1747篇内容 | 8200人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1475277, encodeId=4eaa14e5277a4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系, objectType=article, longId=727865, objectId=1076e2786521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1076e2786521, replyNumber=0, likeNumber=80, createdTime=2022-05-27, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1076e2786521, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1076e2786521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475280, encodeId=a64314e52804d, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Hypertension：根据年龄的血压对糖尿病患者终末期肾脏病的影响, objectType=article, longId=727808, objectId=2c97e278084d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c97e278084d, replyNumber=0, likeNumber=72, createdTime=2022-05-26, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c97e278084d, moduleTitle=Hypertension：根据年龄的血压对糖尿病患者终末期肾脏病的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c97e278084d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475274, encodeId=a72914e5274be, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=JCEM：舒张压和ACR是2型糖尿病患者动脉硬化可改变的危险因素, objectType=article, longId=727628, objectId=9a17e27628b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a17e27628b7, replyNumber=0, likeNumber=135, createdTime=2022-05-25, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a17e27628b7, moduleTitle=JCEM：舒张压和ACR是2型糖尿病患者动脉硬化可改变的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a17e27628b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475273, encodeId=cd7114e527376, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：糖尿病患者体重减轻超过10%，死亡风险将增加两倍多, objectType=article, longId=727474, objectId=e33be2747453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e33be2747453, replyNumber=0, likeNumber=84, createdTime=2022-05-22, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e33be2747453, moduleTitle=Cardiovasc Diabetol：糖尿病患者体重减轻超过10%，死亡风险将增加两倍多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e33be2747453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475276, encodeId=a16c14e5276e1, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=DOM：三联疗法口服药物控制不佳的2型糖尿病患者加用替格列汀的有效性和安全性, objectType=article, longId=727370, objectId=0f88e2737005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f88e2737005, replyNumber=0, likeNumber=52, createdTime=2022-05-21, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f88e2737005, moduleTitle=DOM：三联疗法口服药物控制不佳的2型糖尿病患者加用替格列汀的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f88e2737005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475275, encodeId=9f5714e5275c9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：心血管疾病和下肢截肢对长期1型糖尿病患者全因死亡风险的不同预后影响, objectType=article, longId=727369, objectId=9a18e27369ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a18e27369ba, replyNumber=0, likeNumber=60, createdTime=2022-05-21, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a18e27369ba, moduleTitle=Cardiovasc Diabetol：心血管疾病和下肢截肢对长期1型糖尿病患者全因死亡风险的不同预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a18e27369ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475272, encodeId=813a14e527222, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响, objectType=article, longId=727305, objectId=fc4be2730555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4be2730555, replyNumber=0, likeNumber=72, createdTime=2022-05-20, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4be2730555, moduleTitle=Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4be2730555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475271, encodeId=3e6814e527123, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Stroke：索马鲁肽对2型糖尿病患者卒中亚型的影响, objectType=article, longId=727299, objectId=7b46e27299cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b46e27299cd, replyNumber=0, likeNumber=62, createdTime=2022-05-20, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b46e27299cd, moduleTitle=Stroke：索马鲁肽对2型糖尿病患者卒中亚型的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b46e27299cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475270, encodeId=3b9a14e52709b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=DOM：固定比例的甘精胰岛素联合利司那肽(iGlarLixi)可以改善2型糖尿病患者ß-细胞功能, objectType=article, longId=727226, objectId=ced0e27226ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced0e27226ad, replyNumber=0, likeNumber=76, createdTime=2022-05-19, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced0e27226ad, moduleTitle=DOM：固定比例的甘精胰岛素联合利司那肽(iGlarLixi)可以改善2型糖尿病患者ß-细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced0e27226ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475269, encodeId=8db714e5269c1, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性, objectType=article, longId=727110, objectId=f6d9e2711026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6d9e2711026, replyNumber=0, likeNumber=53, createdTime=2022-05-18, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6d9e2711026, moduleTitle=Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6d9e2711026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475268, encodeId=4c0a14e526899, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=FDA批准双靶向2型糖尿病药物Mounjaro，它能帮助非糖尿病患者减重22.5%！, objectType=article, longId=727036, objectId=c4dfe27036c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4dfe27036c6, replyNumber=0, likeNumber=83, createdTime=2022-05-17, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4dfe27036c6, moduleTitle=FDA批准双靶向2型糖尿病药物Mounjaro，它能帮助非糖尿病患者减重22.5%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4dfe27036c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475266, encodeId=935614e526605, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=专访清华大学程功教授：受糖尿病患者易感新冠启发，发现广谱抗新冠代谢物, objectType=article, longId=726559, objectId=99cce26559eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99cce26559eb, replyNumber=0, likeNumber=89, createdTime=2022-05-12, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99cce26559eb, moduleTitle=专访清华大学程功教授：受糖尿病患者易感新冠启发，发现广谱抗新冠代谢物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99cce26559eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475267, encodeId=d4b914e5267bf, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=BMC Med：成人2型糖尿病患者的糖尿病肾病和卒中风险, objectType=article, longId=726503, objectId=a970e2650338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a970e2650338, replyNumber=0, likeNumber=47, createdTime=2022-05-11, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a970e2650338, moduleTitle=BMC Med：成人2型糖尿病患者的糖尿病肾病和卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a970e2650338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475265, encodeId=148914e5265fc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：血浆磷酸盐水平越高，糖尿病患者的死亡风险越高！, objectType=article, longId=726282, objectId=f974e262821c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f974e262821c, replyNumber=0, likeNumber=70, createdTime=2022-05-08, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f974e262821c, moduleTitle=Cardiovasc Diabetol：血浆磷酸盐水平越高，糖尿病患者的死亡风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f974e262821c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475263, encodeId=10a214e5263a6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：睡眠时间可预测糖尿病患者的长期死亡率！, objectType=article, longId=726094, objectId=679de260944d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=679de260944d, replyNumber=0, likeNumber=75, createdTime=2022-05-05, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=679de260944d, moduleTitle=Cardiovasc Diabetol：睡眠时间可预测糖尿病患者的长期死亡率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=679de260944d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475262, encodeId=8ad214e526277, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制, objectType=article, longId=726070, objectId=b59ee2607052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b59ee2607052, replyNumber=0, likeNumber=126, createdTime=2022-05-05, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b59ee2607052, moduleTitle=Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b59ee2607052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475261, encodeId=adac14e526156, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：CT血管成像时冠脉周围脂肪组织密度高可预测2型糖尿病患者的心血管事件, objectType=article, longId=725592, objectId=7589e2559265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7589e2559265, replyNumber=0, likeNumber=60, createdTime=2022-04-29, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7589e2559265, moduleTitle=Cardiovasc Diabetol：CT血管成像时冠脉周围脂肪组织密度高可预测2型糖尿病患者的心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7589e2559265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475258, encodeId=60b814e52587b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=J Am Heart Assoc：糖尿病患者认知障碍与心血管事件的相关性分析, objectType=article, longId=724978, objectId=bfe2e24978a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfe2e24978a6, replyNumber=0, likeNumber=69, createdTime=2022-04-27, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfe2e24978a6, moduleTitle=J Am Heart Assoc：糖尿病患者认知障碍与心血管事件的相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfe2e24978a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475256, encodeId=78f014e5256aa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=JCEM：低风险生活方式和健康因素与糖尿病患者死亡和血管并发症风险的关系, objectType=article, longId=724934, objectId=e927e24934f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e927e24934f7, replyNumber=0, likeNumber=65, createdTime=2022-04-26, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e927e24934f7, moduleTitle=JCEM：低风险生活方式和健康因素与糖尿病患者死亡和血管并发症风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e927e24934f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475260, encodeId=335c14e526050, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol:在患有超重和肥胖的2型糖尿病患者中，脂肪和肌肉质量与心血管疾病危险因素的性别相关, objectType=article, longId=724840, objectId=3b07e24840fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b07e24840fa, replyNumber=0, likeNumber=59, createdTime=2022-04-24, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b07e24840fa, moduleTitle=Cardiovasc Diabetol:在患有超重和肥胖的2型糖尿病患者中，脂肪和肌肉质量与心血管疾病危险因素的性别相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b07e24840fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖尿病患者

2020-05-29

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系

2022-05-27

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Hypertension：根据年龄的血压对糖尿病患者终末期肾脏病的影响

2022-05-26

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

JCEM：舒张压和ACR是2型糖尿病患者动脉硬化可改变的危险因素

2022-05-25

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：糖尿病患者体重减轻超过10%，死亡风险将增加两倍多

2022-05-22

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

DOM：三联疗法口服药物控制不佳的2型糖尿病患者加用替格列汀的有效性和安全性

2022-05-21

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：心血管疾病和下肢截肢对长期1型糖尿病患者全因死亡风险的不同预后影响

2022-05-21

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响

2022-05-20

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Stroke：索马鲁肽对2型糖尿病患者卒中亚型的影响

2022-05-20

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

DOM：固定比例的甘精胰岛素联合利司那肽(iGlarLixi)可以改善2型糖尿病患者ß-细胞功能

2022-05-19

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性

2022-05-18

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

FDA批准双靶向2型糖尿病药物Mounjaro，它能帮助非糖尿病患者减重22.5%！

2022-05-17

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

专访清华大学程功教授：受糖尿病患者易感新冠启发，发现广谱抗新冠代谢物

2022-05-12

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

BMC Med：成人2型糖尿病患者的糖尿病肾病和卒中风险

2022-05-11

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：血浆磷酸盐水平越高，糖尿病患者的死亡风险越高！

2022-05-08

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：睡眠时间可预测糖尿病患者的长期死亡率！

2022-05-05

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制

2022-05-05

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：CT血管成像时冠脉周围脂肪组织密度高可预测2型糖尿病患者的心血管事件

2022-04-29

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

J Am Heart Assoc：糖尿病患者认知障碍与心血管事件的相关性分析

2022-04-27

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

JCEM：低风险生活方式和健康因素与糖尿病患者死亡和血管并发症风险的关系

2022-04-26

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol:在患有超重和肥胖的2型糖尿病患者中，脂肪和肌肉质量与心血管疾病危险因素的性别相关

2022-04-24

科室
- - 订阅+
  - 更多科室
工具
服务